A screen of FDA-approved drugs with minigenome identified tigecycline as an antiviral targeting nucleoprotein of Crimean-Congo hemorrhagic fever virus by Minato Hirano & Yasuteru Sakurai & Shuzo Urata & Yohei Kurosaki & Jiro Yasuda & Kentaro Yoshii

A screen of FDA-approved drugs with minigenome identified tigecycline as an antiviral targeting nucleoprotein of Crimean-Congo hemorrhagic fever virus by Minato Hirano & Yasuteru Sakurai & Shuzo Urata & Yohei Kurosaki & Jiro Yasuda & Kentaro Yoshii

Author:Minato Hirano & Yasuteru Sakurai & Shuzo Urata & Yohei Kurosaki & Jiro Yasuda & Kentaro Yoshii
Format: pdf
Tags: Crimean-Congo hemorrhagic Fever virus, Minigenome, Drug screening, Tigecycline, Nucleoprotein
Publisher: Elsevier B.V.
Published: 2022-03-25T16:56:53+00:00


Download



Copyright Disclaimer:
This site does not store any files on its server. We only index and link to content provided by other sites. Please contact the content providers to delete copyright contents if any and email us, we'll remove relevant links or contents immediately.